Fact CheckerSign in

NCT07490106Not yet recruiting

Benefits of Early Collaboration Between Oncologists and Palliative Care Physicians in Cases of Unplanned Hospitalization for Patients With Metastatic Cancer

Source: ClinicalTrials.gov · Last updated 17 Sept 2026

Brief summary (registry, in English)

This is a multicenter, national, interventional, cluster-randomized study, "stepped wedge" design. This study includes patients with metastatic or locally advanced digestive, gynecological, ENT, or sarcoma cancer, currently undergoing systemic palliative treatment and hospitalized on an unscheduled basis. The study will aim to evaluate the impact of early palliative care implementation for patients with metastatic or advanced cancer identified during an unplanned hospitalization.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
493 (estimated)
First submitted
16 Mar 2026
Start date
Oct 2026
Primary completion date
Oct 2031
Lead sponsor
Centre Oscar Lambret
Diseases
Sarcoma
NCT number
NCT07490106

What you commit to

  • Study type: Interventional
  • Planned participants: 493
  • From Oct 2026 to the primary completion date, Oct 2031
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patient receiving end-of-life care;

Other

  • PS (WHO) = 4;
  • Patient opposed to the use of medical data for research purposes;
  • Person deprived of liberty or under guardianship;
  • Inability to undergo medical monitoring for the trial for geographical, social, or psychological reasons.

Who the study is looking for

  • Subjects aged 18 years and older;
  • Diagnosed with metastatic or locally advanced digestive, gynecological, ENT, or sarcoma cancer;
  • Currently undergoing systemic palliative treatment (no prospect of cure);
  • Hospitalized on an unscheduled basis (i.e., unplanned hospitalization for scheduled oncology treatments);
  • Patient covered by the French social security system;
  • Informed consent, written and signed.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Centre Oscar Lambret
Coordinator of this site? Confirm its status
LilleFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.